PUBLISHER: Grand View Research | PRODUCT CODE: 1362945
PUBLISHER: Grand View Research | PRODUCT CODE: 1362945
North America Urinary Tract Infection Testing Market Size, Share & Trends Analysis Report By Type, By Product, By End-use, By Country, And Segment Forecasts, 2023 - 2030
North America Urinary Tract Infection Testing Market Growth & Trends:
The North America urinary tract infection testing market size is expected to reach USD 269.16 million by 2030, according to a new study by Grand View Research, Inc.. The market is expected to expand at a CAGR of 4.0% from 2023 to 2030. The regional UTI testing market is growing due to increasing government initiatives regarding UTI control in the region, technological advancements in UTI testing, and highly developed healthcare infrastructure & improved access to healthcare facilities. For instance, an article published by The New York Times in July 2019 mentioned that the New York City Department of Health launched a mobile app to address drug-resistant urinary tract infections (UTIs). The app provides doctors and nurses with a list of infection strains and their resistance to specific drugs.
Research conducted by this department revealed that many of the UTIs caused by E. coli, the most common type, were resistant to widely used drugs like Bactrim. This growing concern over drug-resistant UTIs drives the demand for advanced UTI testing solutions in North America, as healthcare providers seek more accurate and targeted therapies to combat the rising issue of antibiotic resistance. As a result, the UTI testing market in the region is experiencing significant growth.
Incorporating innovative diagnostic technologies can significantly enhance patient care and management while promoting antibiotic stewardship through faster result delivery, thereby driving market growth. For instance, a team of engineers and molecular biologists in the U.S. has developed a cost-effective point-of-care diagnostic test for rapidly detecting microbial pathogens in urine. Using a simple lab kit, LED lights, a hot plate, and a smartphone, the device shows promising potential for quick and low-cost diagnosis of urinary tract infections (UTIs) in resource-limited settings.
Furthermore, a pilot study published in eBioMedicine compared the smartphone-based real-time loop-mediated isothermal amplification (smaRT-LAMP) system to the more expensive rapid diagnostic technologies and standard hospital tests. The results demonstrated that the smaRT-LAMP system matched the accuracy of hospital diagnostics while significantly reducing costs and testing time.
Key players in the regional urinary tract infection testing market, such as F. Hoffmann-La Roche Ltd., bioMerieux SA, T2 Biosystems, Abbott, Siemens Healthcare GmbH, etc., are implementing strategic initiatives such as mergers, acquisitions, and collaborations to enhance product capabilities and promote their offerings. For instance, in November 2022, Illumina, a global leader in DNA sequencing and array-based technologies, introduced the Illumina Urinary Pathogen Infectious Disease/Antimicrobial Resistance (ID/AMR) Panel (UPIP). This research test utilizes precision metagenomics to identify and measure genitourinary pathogens, including drug-resistant ones that lead to complicated and recurrent urinary tract infections (UTIs).
North America Urinary Tract Infection Testing Market Report Highlights:
- The growth of the overall market is attributed to the increasing prevalence of UTIs among the population in the region
- The UTI testing market is witnessing a key shift with the rise in demand for technologically advanced homecare UTI testing kits
- Cystitis held the largest market share of 41.41% in 2022, owing to the high incidence & recurrence rate of cystitis in patients
- The instruments segment dominated the market with a revenue share of 60.36% in 2022. This is attributed to advancements in diagnostic technologies that have led to the development of sophisticated instruments with enhanced capabilities
- Based on end-use, the reference laboratories segment accounted for the largest revenue share of 26.11% in 2022. This is attributed to the wide range of comprehensive testing services offered by these laboratories
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.1.1. Segment Definitions
- 1.1.1.1. Type segment
- 1.1.1.2. Product segment
- 1.1.1.3. End-user segment
- 1.1.1. Segment Definitions
- 1.2. Regional Scope
- 1.3. Estimates and Forecast Timeline
- 1.4. Objectives
- 1.4.1. Objective - 1
- 1.4.2. Objective - 2
- 1.4.3. Objective - 3
- 1.5. Research Methodology
- 1.6. Information Procurement
- 1.6.1. Purchased Database
- 1.6.2. GVR's Internal Database
- 1.6.3. Secondary Sources
- 1.6.4. Primary research
- 1.7. Information or Data Analysis
- 1.7.1. Data Analysis Models
- 1.8. Market Formulation & Validation
- 1.9. Model Details
- 1.9.1. Commodity Flow Analysis
- 1.10. List of Secondary Sources
- 1.11. List of Abbreviations
Chapter 2. Executive Summary
- 2.1. Market Snapshot
- 2.2. Product and Type Snapshot
- 2.3. End-use Snapshot
- 2.4. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/Ancillary Market Outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.1.1. Increasing prevalence of urinary tract infections (UTIs)
- 3.2.1.2. Technological Advancements in Urinary Tract Infection Testing
- 3.2.1.3. Growing prevalence of catheter-associated UTIs (CAUTIs)
- 3.2.2. Market Restraint Analysis
- 3.2.2.1. High cost associated with advanced UTI testing technologies.
- 3.2.1. Market Driver Analysis
- 3.3. Industry Analysis Tools
- 3.3.1. Porter's Five Forces Analysis
- 3.3.2. PESTEL Analysis
- 3.3.3. COVID-19 Impact Analysis
Chapter 4. North America Urinary Tract Infection Testing Market: Type Analysis
- 4.1. North America Urinary Tract Infection Testing Market: Type Movement Analysis
- 4.2. Urethritis
- 4.2.1. Urethritis Market, 2018 - 2030 (USD Million)
- 4.3. Cystitis
- 4.3.1. Cystitis Market, 2018 - 2030 (USD Million)
- 4.4. Pyelonephritis
- 4.4.1. Pyelonephritis Market, 2018 - 2030 (USD Million)
Chapter 5. North America Urinary Tract Infection Testing Market: Product Analysis
- 5.1. North America Urinary Tract Infection Testing Market: Product Movement Analysis
- 5.2. Instruments
- 5.2.1. Instruments Market, 2018 - 2030 (Revenue, USD Million; Volume, Units, 2018 - 2030)
- 5.3. Consumables
- 5.3.1. Consumables Market, 2018 - 2030 (Revenue, USD Million; Volume, Units, 2018 - 2030)
Chapter 6. North America Urinary Tract Infection Testing Market: End-use Analysis
- 6.1. North America Urinary Tract Infection Testing Market: End-use Movement Analysis
- 6.2. General Practitioners
- 6.2.1. General Practitioners Market, 2018 - 2030 (Revenue, USD Million; Volume, Units, 2018 - 2030)
- 6.3. Urologists
- 6.3.1. Urologists Market, 2018 - 2030 (Revenue, USD Million; Volume, Units, 2018 - 2030)
- 6.4. Urogynecologists
- 6.4.1. Urogynecologists Market, 2018 - 2030 (Revenue, USD Million; Volume, Units, 2018 - 2030)
- 6.5. Hospital Laboratories
- 6.5.1. Hospital Laboratories Market, 2018 - 2030 (Revenue, USD Million; Volume, Units, 2018 - 2030)
- 6.6. Reference Laboratories
- 6.6.1. Reference Laboratories Market, 2018 - 2030 (Revenue, USD Million; Volume, Units, 2018 - 2030)
- 6.7. Hospital Emergency Departments
- 6.7.1. Hospital Emergency Departments Market, 2018 - 2030 (Revenue, USD Million; Volume, Units, 2018 - 2030)
- 6.8. Urgent Care
- 6.8.1. Urgent Care Market, 2018 - 2030 (Revenue, USD Million; Volume, Units, 2018 - 2030)
- 6.9. Others
- 6.9.1. Others Market, 2018 - 2030 (Revenue, USD Million; Volume, Units, 2018 - 2030)
Chapter 7. North America Urinary Tract Infection Testing Market: Regional Analysis
- 7.1. North America
- 7.1.1. SWOT Analysis
- 7.1.2. North America Urinary Tract Infection Testing Market, 2018 - 2030 (USD Million)
- 7.1.3. U.S.
- 7.1.3.1. Key Country Dynamics
- 7.1.3.2. Target Disease Prevalence
- 7.1.3.3. Competitive Scenario
- 7.1.3.4. Regulatory Framework
- 7.1.3.5. U.S. Urinary Tract Infection Testing Market, 2018 - 2030 (USD Million)
- 7.1.4. Canada
- 7.1.4.1. Key Country Dynamics
- 7.1.4.2. Target Disease Prevalence
- 7.1.4.3. Competitive Scenario
- 7.1.4.4. Regulatory Framework
- 7.1.4.5. Canada Urinary Tract Infection Testing Market, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
- 8.1. Participant Categorization
- 8.1.1. QIAGEN
- 8.1.1.1. Overview
- 8.1.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 8.1.1.3. Product Benchmarking
- 8.1.1.4. Strategic Initiatives
- 8.1.2. Accelerate Diagnostics, Inc.
- 8.1.2.1. Overview
- 8.1.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 8.1.2.3. Product Benchmarking
- 8.1.2.4. Strategic Initiatives
- 8.1.3. Bio-Rad Laboratories, Inc.
- 8.1.3.1. Overview
- 8.1.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 8.1.3.3. Product Benchmarking
- 8.1.3.4. Strategic Initiatives
- 8.1.4. F. Hoffmann-La Roche Ltd.
- 8.1.4.1. Overview
- 8.1.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 8.1.4.3. Product Benchmarking
- 8.1.4.4. Strategic Initiatives
- 8.1.5. Danaher Corporation
- 8.1.5.1. Overview
- 8.1.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 8.1.5.3. Product Benchmarking
- 8.1.5.4. Strategic Initiatives
- 8.1.6. Siemens Healthcare GmbH
- 8.1.6.1. Overview
- 8.1.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 8.1.6.3. Product Benchmarking
- 8.1.6.4. Strategic Initiatives
- 8.1.7. Randox Laboratories Ltd.
- 8.1.7.1. Overview
- 8.1.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 8.1.7.3. Product Benchmarking
- 8.1.7.4. Strategic Initiatives
- 8.1.8. Thermo Fisher Scientific, Inc.
- 8.1.8.1. Overview
- 8.1.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 8.1.8.3. Product Benchmarking
- 8.1.8.4. Strategic Initiatives
- 8.1.9. bioMerieux SA
- 8.1.9.1. Overview
- 8.1.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 8.1.9.3. Product Benchmarking
- 8.1.9.4. Strategic Initiatives
- 8.1.10. T2 Biosystems, Inc.
- 8.1.10.1. Overview
- 8.1.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 8.1.10.3. Product Benchmarking
- 8.1.10.4. Strategic Initiatives
- 8.1.1. QIAGEN
- 8.2. Participant's Overview
- 8.3. Financial Performance
- 8.4. Product Benchmarking
- 8.5. Company Market Share Analysis, 2022
- 8.6. Strategy Mapping
- 8.6.1. Expansions
- 8.6.2. Acquisitions
- 8.6.3. Product/Service Launches
- 8.6.4. Others
Chapter 9. Conclusion/Analyst Perspective
List of Tables
- 1. List of Secondary Sources
- 2. List of Abbreviations
- 3. North America Urinary Tract Infection Testing Market, By Country, 2018 - 2030 (USD Million)
- 4. North America Urinary Tract Infection Testing Market, By Type, 2018 - 2030 (USD Million)
- 5. North America Urinary Tract Infection Testing Market, By Product, 2018 - 2030 (Revenue, USD Million; Volume, Units, 2018 - 2030)
- 6. North America Urinary Tract Infection Testing Market, by End - use, 2018 - 2030 (Revenue, USD Million; Volume, Units, 2018 - 2030)
- 7. U.S. Urinary Tract Infection Testing Market, by Type, 2018 - 2030 (USD Million)
- 8. U.S. Urinary Tract Infection Testing Market, By Product, 2018 - 2030 (Revenue, USD Million; Volume, Units, 2018 - 2030)
- 9. U.S. Urinary Tract Infection Testing Market, by End - use, 2018 - 2030 (Revenue, USD Million; Volume, Units, 2018 - 2030)
- 10. Canada Urinary Tract Infection Testing Market, by Type, 2018 - 2030 (USD Million)
- 11. Canada Urinary Tract Infection Testing Market, By Product, 2018 - 2030 (Revenue, USD Million; Volume, Units, 2018 - 2030)
- 12. Canada Urinary Tract Infection Testing Market, by End - use, 2018 - 2030 (Revenue, USD Million; Volume, Units, 2018 - 2030)
List of Figures
- 1. Market research process
- 2. Information procurement
- 3. Primary research pattern
- 4. Market research approaches
- 5. Value chain - based sizing & forecasting
- 6. Market formulation & validation
- 7. North America urinary tract infection testing: Market segmentation
- 8. Market snapshot, 2022
- 9. Market Trends & Outlook
- 10. Market driver relevance analysis (current & future impact)
- 11. Market restraint relevance analysis (current & future impact)
- 12. Market challenge relevance analysis (current & future impact)
- 13. SWOT analysis
- 14. Porter's five forces analysis
- 15. North America urinary tract infection testing market: Type outlook and key takeaways
- 16. North America urinary tract infection testing market: Type movement analysis & market share, 2022 & 2030
- 17. Urethritis market estimates and forecast, 2018 - 2030 (USD Million)
- 18. Cystitis market estimates and forecast, 2018 - 2030 (USD Million)
- 19. Pyelonephritis market estimates and forecast, 2018 - 2030 (USD Million)
- 20. North America urinary tract infection testing market: Product outlook and key takeaways
- 21. North America urinary tract infection testing market: Product movement analysis & market share, 2022 & 2030
- 22. Instruments market estimates and forecast, 2018 - 2030 (Revenue, USD Million; Volume, Units, 2018 - 2030)
- 23. Consumables market estimates and forecast, 2018 - 2030 (Revenue, USD Million; Volume, Units, 2018 - 2030)
- 24. North America urinary tract infection testing market: End - use outlook and key takeaways
- 25. North America urinary tract infection testing market: End - use movement analysis & market share, 2022 & 2030
- 26. General practitioners market estimates and forecast, 2018 - 2030 (Revenue, USD Million; Volume, Units, 2018 - 2030)
- 27. Urologists market estimates and forecast, 2018 - 2030 (Revenue, USD Million; Volume, Units, 2018 - 2030)
- 28. Urogynecologists market estimates and forecast, 2018 - 2030 (Revenue, USD Million; Volume, Units, 2018 - 2030)
- 29. Hospital laboratories market estimates and forecast, 2018 - 2030 (Revenue, USD Million; Volume, Units, 2018 - 2030)
- 30. Reference laboratories market estimates and forecast, 2018 - 2030 (Revenue, USD Million; Volume, Units, 2018 - 2030)
- 31. Hospital emergency departments market estimates and forecast, 2018 - 2030 (Revenue, USD Million; Volume, Units, 2018 - 2030)
- 32. Urgent care market estimates and forecast, 2018 - 2030 (Revenue, USD Million; Volume, Units, 2018 - 2030)
- 33. Others market estimates and forecast, 2018 - 2030 (Revenue, USD Million; Volume, Units, 2018 - 2030)
- 34. Regional marketplace: key takeaways
- 35. Regional outlook, 2022 & 2030
- 36. North America urinary tract infection testing market: region movement analysis.
- 37. North America urinary tract infection testing market, 2018 - 2030 (Revenue, USD Million, 2018 - 2030)
- 38. U.S. key country dynamics
- 39. U.S. urinary tract infection testing market, 2018 - 2030 (Revenue, USD Million, 2018 - 2030)
- 40. Canada key country dynamics
- 41. Canada urinary tract infection testing market, 2018 - 2030 (Revenue, USD Million, 2018 - 2030)
